Superbloom,” by Nicholas Carr, and “The Sirens’ Call,” by the MSNBC host Chris Hayes, argue that we are ill equipped to ...
Fable, a popular social media app that describes itself as a haven for “bookworms and bingewatchers,” created an AI-powered end-of-year summary feature recapping what books users read in 2024.
George Oppen’s “From a Photograph” turns a wintry snapshot into a moving meditation on parenthood and the passage of time. Our critic A.O. Scott shows you what he loves about it. By A.O ...
Back in 1934, Ralph Nelson Elliott discovered that price action displayed on charts, instead of behaving in a somewhat chaotic manner, had actually an intrinsic narrative attached. Elliot saw the ...
Our current decade has brought in some great recent reads — see our picks here Carly Tagen-Dye is the Books editorial assistant at PEOPLE, where she writes for both print and digital platforms.
In her new book, Cho Nam-Joo captures both the universality of sexism and the specificity of women’s experiences. When I was young and adrift, Thomas Mann’s novel gave me a sense of purpose.
In Kwame Alexander’s new verse novel and Karen L. Swanson’s nonfiction picture book, Black girls pursue their dreams of playing big-league baseball. As spooky season approaches, the master of ...
The latest book in the phenomenally popular romance-fantasy Empyrean Series finds Violet Sorrengail leaving Basgiath War College, where she’s been studying to be a dragon rider, and venturing ...
Welcome to the L.A. Times Book Club newsletter. Hello, fellow readers. I’m culture critic and fervent bookworm Chris Vognar. Another year of reading has come and gone, leaving mental trails of ...
And once you begin investing, there's always more to learn. Personal finance books about investing can be great learning tools, regardless of where you are in your journey. The following investing ...
“Shattered” recounts the experience and its aftermath. In his new book “Everything Must Go,” Dorian Lynskey recounts two millennia of apocalyptic predictions. Amazingly, it’s not depressin ...
A rapid and efficient method developed to create stem-cell-based 3D mini-organs derived from the cells of patients offers a way to evaluate personalized treatments using RNA therapies for rare ...